Finance

Lists
Why is AVTX up ၄.၅၂%?
Dive Deeper
AVTX:NASDAQ
Avalo Therapeutics Inc
၆.၉၃ US$
+၄.၅၂%
(+၀.၃၀) 1D
၇.၀၅ US$
+၁.၇၃% (+၀.၁၂)
After hours
Closed: နို ၆, GMT-၅ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVTX...
Open
၆.၉၀ US$
High
၇.၀၀ US$
Low
၆.၅၃ US$
Mkt. cap
၃၇.၁၇ ကုဋေ
Avg. vol.
၂.၃၀ သန်း
Volume
၁.၁၁ သန်း
52-wk high
၂၄.၂၇ US$
52-wk low
၆.၅၃ US$
EPS
-၄.၇၅ US$
Beta
၀.၇၅
Shares outstanding
၅.၃၆ ကုဋေ
No. of employees
၃၃
Open
၆.၉၀ US$
High
၇.၀၀ US$
Low
၆.၅၃ US$
Mkt. cap
၃၇.၁၇ ကုဋေ
Avg. vol.
၂.၃၀ သန်း
Volume
၁.၁၁ သန်း
52-wk high
၂၄.၂၇ US$
52-wk low
၆.၅၃ US$
EPS
-၄.၇၅ US$
Beta
၀.၇၅
Shares outstanding
၅.၃၆ ကုဋေ
No. of employees
၃၃
News stories
From web sources and news partners
About Avalo Therapeutics Inc
CEO-
Employees၃၃
Founded၂၀၁၁
HeadquartersRockville, ပင်ဆယ်ဗေးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Analyst ratings
Based on 7 analysts giving stock ratings to AVTX in the past 3 months
Buy
Buy
5
Hold
2
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AVTX in the last 3 months.
Highest
Current ၆.၉၃ US$
၆၀.၀၀ US$ (+၇၆၅.၈၀%)
Average
၂၆.၀၀ US$ (+၂၇၅.၁၈%)
Lowest
၁၀.၀၀ US$ (+၄၄.၃၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Reiterated
၂၀.၀၀ US$
+၁၈၈.၆%
11/06/2026
Julian Harrison
BTIG
Buy
Maintained
၁၀.၀၀ US$
+၄၄.၃%
11/05/2026
Mitchell Kapoor
H.C. Wainwright
Hold
Reiterated
-
-
11/06/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
၂၄.၀၀ US$
+၂၄၆.၃%
11/06/2026
Leland Gershell
Oppenheimer
Buy
Maintained
၁၆.၀၀ US$
+၁၃၀.၉%
10/26/2026
Yatin Suneja
Guggenheim
Hold
Downgraded
-
-
10/23/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
၆၀.၀၀ US$
+၇၆၅.၈%
10/01/2026
Thomas Smith
Leerink Partners
Buy
Initiated
၃၈.၀၀ US$
+၄၄၈.၃%
07/06/2026
Stacy Ku
TD Cowen
Buy
Maintained
-
-
06/11/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
၃၉.၀၀ US$
+၄၆၂.၈%
05/15/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
၄၅.၀၀ US$
+၅၄၉.၄%
05/14/2026
Jason Butler
Citizens JMP
Buy
Maintained
၅၅.၀၀ US$
+၆၉၃.၇%
05/14/2026
Andy Chen
Wolfe Research
Buy
Initiated
၄၈.၀၀ US$
+၅၉၂.၆%
04/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၅.၉၀ သောင်း
-
-
-
Cost of goods sold
၈.၇၈ သန်း
၁.၀၁ ကုဋေ
၁.၉၀ ကုဋေ
-
Cost of revenue
၈.၇၈ သန်း
၁.၀၁ ကုဋေ
၁.၉၀ ကုဋေ
-
Research and development expenses
၄.၄၈ သန်း
၃.၉၀ သန်း
၄.၃၉ သန်း
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၆.၅၃ သန်း
၆.၈၅ သန်း
၈.၁၀ သန်း
-
Operating expense
၁.၁၀ ကုဋေ
၁.၀၈ ကုဋေ
၁.၂၅ ကုဋေ
-
Total operating expenses
၁.၉၈ ကုဋေ
၂.၀၉ ကုဋေ
၃.၁၅ ကုဋေ
-
Operating income
-၁.၉၇ ကုဋေ
-၂.၀၉ ကုဋေ
-၃.၁၅ ကုဋေ
-
Other non operating income
၅.၁၇ သန်း
၄.၈၀ သိန်း
-၇.၅၈ သန်း
-
EBT including unusual items
-၁.၃၆ ကုဋေ
-၁.၉၆ ကုဋေ
-၃.၆၃ ကုဋေ
-
EBT excluding unusual items
-၁.၃၆ ကုဋေ
-၁.၉၆ ကုဋေ
-၃.၆၃ ကုဋေ
-
Income tax expense
၁.၃၀ သိန်း
၁.၂၀ သောင်း
၁.၈၀ သောင်း
-
Effective tax rate
-၀.၉၆%
-၀.၀၆%
-၀.၀၅%
-
Other operating expenses
-
-
-
-
Net income
-၁.၃၇ ကုဋေ
-၁.၉၆ ကုဋေ
-၃.၆၄ ကုဋေ
-
Net profit margin
-၂၃,၂၅၄.၂၄%
-
-
-
Earnings per share
-၀.၃၇
-၀.၉၈
-၀.၈၃
-၀.၃၄
Interest and investment income
၉.၈၄ သိန်း
၈.၀၃ သိန်း
၂.၇၆ သန်း
-
Interest expense
-
-
-
-
Net interest expenses
၉.၈၄ သိန်း
၈.၀၃ သိန်း
၂.၇၆ သန်း
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၉၇ ကုဋေ
-၂.၀၉ ကုဋေ
-၃.၁၅ ကုဋေ
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ